<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="table3-1759720X20947296" orientation="portrait" position="float">
 <label>Table 3.</label>
 <caption>
  <p>Mechanisms regarding antiviral activities of DMARDs and immunosuppressants.</p>
 </caption>
 <alternatives>
  <graphic xlink:href="10.1177_1759720X20947296-table3" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" span="1"/>
    <col align="char" char="." span="1"/>
    <col align="char" char="." span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Medications</th>
     <th align="left" rowspan="1" colspan="1">Viral susceptibility</th>
     <th align="left" rowspan="1" colspan="1">Proposed antiviral mechanisms</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td rowspan="1" colspan="1">
      <bold>Chloroquine</bold>
      <break/>
      <bold>HCQ</bold>
     </td>
     <td rowspan="1" colspan="1">SARS-CoV, HIV, dengue virus, chikungunya virus, influenza A virus, HCV, Zika virus</td>
     <td rowspan="1" colspan="1">(1) Increase endosomal pH required for virus/cell fusion
      <break/>(2) Interfere with the glycosylation of cellular receptors
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">
      <bold>Cyclosporine A</bold>
     </td>
     <td rowspan="1" colspan="1">HIV</td>
     <td rowspan="1" colspan="1">Inhibit cyclophilins to incorporate into new virion, which is essential for virus infectivity</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">HCV genotype 1</td>
     <td rowspan="1" colspan="1">Inhibit host cyclophilins to form replication complex with NS5A/B of HCV, and influence protein folding and trafficking</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Flavivirus (Zika virus, dengue virus, West Nile virus, yellow fever virus)</td>
     <td rowspan="1" colspan="1">Block the interaction between host cyclophilins and flaviviral NS5 protein</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Betaretrovirus</td>
     <td rowspan="1" colspan="1">Interrupt life cycle from:
      <break/>(1) viral protein synthesis
      <break/>(2) gag and envelope assembly
      <break/>(3) particle budding
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">
      <bold>Hydroxyurea</bold>
     </td>
     <td rowspan="1" colspan="1">HIV</td>
     <td rowspan="1" colspan="1">(1) Inhibit DNA synthesis, slowing production of viral DNA
      <break/>(2) Deplete dNTP pools, which increase competitive ability of NRTIs to incorporate into HIV-1 DNA chain
      <break/>(3) Enhance NRTI phosphorylation, reducing resistance to NRTIs
      <break/>(4) Reduce cellular division of CD4+ T lymphocytes
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">HCV</td>
     <td rowspan="1" colspan="1">Inhibit HCV RNA replication</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">HBV</td>
     <td rowspan="1" colspan="1">Unknown, inhibit HBV replication</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">HSV</td>
     <td rowspan="1" colspan="1">Inhibit HSV DNA replication</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Parvovirus B19</td>
     <td rowspan="1" colspan="1">Unknown</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">
      <bold>Minocycline</bold>
     </td>
     <td rowspan="1" colspan="1">HIV</td>
     <td rowspan="1" colspan="1">(1) High affinity to HIV integrase and interaction with HIV integrase suppress the virus
      <break/>(2) Decrease viral expression from CD4+ T cells
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Japanese encephalitis virus</td>
     <td rowspan="1" colspan="1">Inhibit microglial activation and neuronal apoptosis</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Dengue virus</td>
     <td rowspan="1" colspan="1">Reduce viral RNA synthesis, intracellular envelope protein expression, and the production of infectious virions</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">RSV</td>
     <td rowspan="1" colspan="1">(1) Reduce RSV-mediated cytopathic effects
      <break/>(2) Prevent RSV infection by affecting RSV F protein production or maturation
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Enterovirus 71</td>
     <td rowspan="1" colspan="1">Reduce cytopathic effects and viral protein expressions</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Influenza virus</td>
     <td rowspan="1" colspan="1">Reverse H7N9 replication</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">West Nile virus</td>
     <td rowspan="1" colspan="1">Anti-apoptotic properties result in neuroprotection.</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Reovirus</td>
     <td rowspan="1" colspan="1">Reduce apoptosis and antigen expression</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Rabies</td>
     <td rowspan="1" colspan="1">Reduce CD3+ cells may impair the host to control disease</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">
      <bold>Mycophenolate mofetil/mycophenolic acid</bold>
     </td>
     <td rowspan="1" colspan="1">HIV</td>
     <td rowspan="1" colspan="1">Inhibit the dividing CD4+ T cells, and hence cytostatic and antiviral effect by depletion of this substrate</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">Influenza virus</td>
     <td rowspan="1" colspan="1">Inhibit viral mRNA and protein expression 
      <italic>via</italic> inhibition of cellular IMPDH
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"/>
     <td rowspan="1" colspan="1">MERS-CoV</td>
     <td rowspan="1" colspan="1">Unknown</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">
      <bold>Leflunomide</bold>
     </td>
     <td rowspan="1" colspan="1">HSV, HIV, molluscum and verruca, CMV, BKV, RSV</td>
     <td rowspan="1" colspan="1">Inhibit nucleocapsid tegumentation and thus prevents virion assembling</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">
      <bold>Tofacitinib</bold>
     </td>
     <td rowspan="1" colspan="1">HTLV-1</td>
     <td rowspan="1" colspan="1">HTLV-1-induced ATLL is associated with JAK3 mutations; tofacitinib inhibits JAK3</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">
      <bold>Thalidomide</bold>
     </td>
     <td rowspan="1" colspan="1">HHV-8</td>
     <td rowspan="1" colspan="1">Unknown, suspect anti-angiogenesis and make immune system able to trigger antiviral response</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="table-fn5-1759720X20947296">
   <p>AAK1, AP2-associated protein kinase 1; ATLL, adult T-cell lymphoma/leukemia; BKV, BK virus; CMV, cytomegalovirus; DENV, dengue virus; DMARDs, disease-modifying anti-rheumatic drugs; DNA, deoxyribonucleic acid; dTNP, deoxynucleoside triphosphate; GAK, cyclin G-associated kinase; HAART, highly active antiretroviral therapy; HBV, hepatitis B virus; HCQ, hydroxychloroquine; HHV-8, human herpesvirus 8; HIV, human immunodeficiency virus; HTLV-I, human T-cell lymphotrophic virus-1; IMPDH, inosine monophosphate dehydrogenase; JAK, Janus kinase; MERS-CoV, Middle East respiratory syndrome coronavirus; mRNA, messenger RNA; NRTI, nucleoside analog reverse-transcriptase inhibitor; RCT, randomized-controlled trial; RNA, ribonucleic acid; RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
